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Abstract
Background: Intracranial pressure (ICP) monitoring is widely used in the management of patients with severe
traumatic brain injury (TBI). However, there is limited evidence about the efficacy of ICP monitoring in older
subjects (aged ≥65 years). This study evaluated the effect of intraventricular ICP monitoring on the outcome of
older adults suffering from a severe TBI.
Methods: This prospective, observational study included 166 older TBI patients (aged ≥65 years) with Glasgow
Coma scale (GCS) scores lower than 9 at admission. The study cohort was divided into two groups, intraventricular
ICP monitoring and non-ICP monitoring. The primary outcome was in-hospital mortality. The secondary outcomes
included the Glasgow Outcome Scale (GOS) score 6 months after injury, the ICU and total hospital lengths of stay,
and mechanical ventilation days.
Results: There were 80 patients in the intraventricular ICP monitoring group and 86 patients in non-ICP monitoring
group. There was no statistical difference between groups in demographics and severity of head injury. Patients
treated with intraventricular ICP monitoring had lower in-hospital mortality (33.8 % vs 51.2 %, P < 0.05), a higher
6-month GOS score (3.0 ± 1.4 vs 2.5 ± 1.2 P < 0.05), and a lower dosage (514 ± 246 g vs 840 ± 323 g, P < 0.0001) and
shorter duration (7.2 ± 3.6 days vs 8.4 ± 4.3 days, P < 0.01) of mannitol use. However, the ICU length of stay (14.3 ± 6.
4 days vs 11.6 ± 5.8 days, P < 0.01) and mechanical ventilation days (6.7 ± 3.5 days vs 5.6 ± 2.4 days, P < 0.05) were
longer in the ICP monitoring group. The total length of hospital stay did not differ between the two groups (28.5 ±
12.1 days vs 26.1 ± 13.5 days, P = 0.23).
Conclusions: Intraventricular ICP monitoring may have beneficial effects on the decreased in-hospital mortality and
improved 6-month outcome of older patients with severe TBI. However, given that this was an observational study
conducted in a single institution, further well-designed randomized control trials are needed to evaluate the effect
of intraventricular ICP monitoring on the outcome of older severe TBI patients.
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Background
Traumatic brain injury (TBI) is a social and economic
problem worldwide. It is the leading cause of death and
disability among young individuals [1]. However, with
the aging population, the proportion of older people
(aged ≥65 years) with a TBI is expected to increase sig-
nificantly in the United States and other developed
countries [2]. Evidence suggests that in the United States
TBI-related hospital visits among older adults are in-
creasing at a rate that exceeds the population growth
[3]. It is widely acknowledged that older adults who suf-
fered from a TBI tend to have poorer outcome and
slower recovery than younger ones even after milder
injuries [2, 4]. The poorer outcomes observed in older
patients suggest that the clinical condition of TBI in
older adults may be different from that of the younger
population; thus, the older group of patients may require
special treatment for a TBI. However, age-specific treat-
ment guidelines for TBI do not currently exist.
Intracranial pressure (ICP) monitoring is considered the
standard of care for severe TBI and has been recom-
mended by several guidelines [5–7]. Although, the efficacy
of ICP monitoring-based treatment remains controversial,
some studies showed improved outcome [8–10] with ICP
monitoring; while, others reported no benefits [11, 12] or
even worsening outcomes [13]. Recent accumulating evi-
dence suggested ICP monitoring only benefits some sub-
groups or subtypes of TBI patients. Therefore, it is
necessary to identify these subgroups [14, 15]. In older
adults, TBI differs in multiple ways from other age groups,
even those experiencing the same injuries [3]. To the best
of our knowledge, few studies have examined the role of
ICP monitoring in this subgroup of TBI patients. Intra-
ventricular ICP monitoring is widely used in clinical prac-
tice because it is accurate and reliable. It also provides an
option of lowering ICP by draining cerebrospinal fluid
(CSF) [16, 17]. The aim of this study was to evaluate the
effect of intraventricular ICP monitoring on the outcome
of older individuals with severe a TBI.
Methods
Protocol approval and patient consent
This observational, prospective study was conducted in
the neurosurgical department of Renji Hospital, affiliated
with Shanghai Jiao Tong University School of Medicine.
The protocol of the present study was approved by the
Ethics Committee of Shanghai Renji Hospital. Verbal in-
formed consent was obtained for all follow-up interviews
by phone, and written informed consent was obtained
for outcome assessments via postal questionnaire.
Sample size calculation
Sample size was calculated using two proportions power
analysis on the basis of the primary outcome measure. It
was estimated that 80 patients per group would be re-
quired for the power analysis. Power (1-β) was set at
0.80, and the type I error (α) was set at 0.1.
Patients
All patients presenting with a TBI from January 2008 to
June 2014 in the study hospital were screened for eligibil-
ity. Inclusion criteria were a) aged ≥65 years; b) history of
acute TBI; c) Glasgow Coma Scale (GCS) score lower than
9 at admission; and d) initial computed tomography (CT)
scan showed intracranial abnormalities consistent with
head trauma. Patients who died within 24 h of brain injury
or were admitted with a diagnosis of brain death were ex-
cluded from the study. Those admitted to our department
24 h after sustaining the injury were also excluded.
Study group and treatment protocol
Subjects in this study were arranged in two groups, the
ICP monitoring group (using an intraventricular ICP
monitor) and non-ICP monitoring group (control group).
Indications for ICP monitoring were: a) severe TBI with
an abnormal CT scan at presentation or b) severe TBI
with a normal CT scan and the presence of two or more
of the following features at admission: age older than
40 years, motor posturing, or systolic blood pressure lower
than 90 mmHg [18]. Although guidelines on ICP monitor-
ing have been adopted by our department, its implemen-
tation was not universal. Patients in the control group met
the criteria of ICP monitoring, but were not monitored
for several reasons, including: the judgment and experi-
ence of the neurosurgeons, the patient’s or their caregiver’s
decision to receive more conservative treatment, and the
limited availability of monitoring devices and trained staff
for inserting the ICP monitor.
Patients with a TBI were managed according to a stan-
dardized protocol based on the guidelines set up by the
Brain Trauma Foundation. For patients in both groups,
the clinical neurological status (GCS score, pupil size,
and reactivity) was monitored hourly. Head CT were ob-
tained at admission, 48 h, 5 to 7 days after admission,
and any time as needed based on the clinical condition.
Invasive mean arterial pressure was measured and main-
tained between 70 mmHg and 100 mmHg. Patients were
positioned in a 30° head-up position and initially sedated
with benzodiazepine and an opioid. Phenytoin was given
for seven days as prophylaxis for early post-traumatic
seizure, and a stress ulcer prophylaxis and thrombo-
embolic prophylaxis were given as appropriate. Nutri-
tional support was provided with early enteral feeding.
In the intraventricular ICP monitoring group, when
the ICP was higher than 20 mmHg, the CSF was drained
and mannitol or a diuretic was administered to maintain
the ICP below this threshold. Drainage of CSF was inter-
mittent to remove the smallest volume of fluid necessary
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to control ICP. The cerebral perfusion pressure (CPP)
was maintained between 60 mmHg and 70 mmHg. Re-
fractory intracranial hypertension was defined as an ICP
increase to more than 30 mmHg or a reduction in CPP
to less than 60 mmHg for a period of more than 15 min,
along with failure to respond to the above-mentioned
maximum medical treatment. If refractory intracranial
hypertension occurred, a decompressive craniotomy was
performed as soon as possible. For patients in the non-
ICP monitoring group, ICP and CPP were not moni-
tored; thus, the management was solely based on clinical
and radiologic findings. Mannitol (0.25–1.0 g/kg) was
routinely administered every 6 or 8 h to maintain os-
motic pressure at 310–320 mOsm/L.
Data collection
Data were collected from medical records by trained re-
search staff, and the variables included were: a) demo-
graphic data, such as age, gender, race, ethnicity, and
chronic conditions (comorbidities); b) injury mechanism,
GCS scores at admission, pupillary reactions; c) injury
severity measured by the Injury Severity Score (ISS) and
Abbreviated Injury Scores (AIS); d) length of intensive
care unit (ICU) stay, total hospital stay, mechanical ven-
tilation days; e) duration of ICP monitoring, mannitol
administration, and CSF drainage; and f ) device-related
complications.
The CT scans obtained at admission were reviewed by
two independent physicians and were classified accord-
ing to the Marshall scale. The Marshall classification of
TBI is based on a review of CT scans, with diffuse injury
I indicating no visible pathology; diffuse injury II indicat-
ing the presence of cisterns, with a midline shift of 0 to
5 mm; diffuse injury III indicating pathology similar to
that in diffuse injury II, but with swelling; and diffuse in-
jury IV indicating pathology similar to that seen in dif-
fuse injuries II or III, with a midline shift of more than
5 mm [19].
Outcome assessment
The primary outcome of this study was in-hospital mor-
tality. Secondary outcomes included the Glasgow Out-
come Scale (GOS) score 6 months later, ICU and total
hospital length of stays, and mechanical ventilation days.
The 6-month GOS score was obtained by outpatient
follow-up or telephone interview.
Statistical analysis
All statistical analyses were performed using SPSS 20.0
(IBM, New York, NY). Unless stated otherwise, a P value
<0.05 was considered statistically significant. Continuous
variables were expressed as the mean and standard devi-
ation. Categorical variables were described as numbers
and percentages. The univariate analyses of categorical
data were performed with a chi-square test. Normally
distributed variables were compared using the Student t-
test; whereas, non-normally distributed variables were
compared using the Mann-Whitney U-test.
Results
Patient demographics and early characteristics
A total of 166 patients (aged ≥65 years) with a severe
TBI, admitted to the neurosurgical department of the
study hospital between January 2008 and June 2014,
were enrolled in our study. Eighty patients received
treatment with intraventricular ICP monitoring and 86
patients were treated without ICP monitoring (Fig. 1).
The demographic and clinical characteristics of both
groups are summarized in Table 1. Falls were the leading
cause of head injury in both groups (53.8 and 55.8 %, re-
spectively), followed by traffic accidents (30 and 32.6 %,
respectively). The proportions of females in both groups
(57.5 and 60.5 %, respectively) were higher than for
males (42.5 and 39.5 %, respectively). With regard to CT
findings, patients who sustained a Marshall CT classifi-
cation of II were more likely to receive treatment with-
out ICP monitoring (16.3 % vs 31.4 %, P < 0.05). Age,
gender, comorbidities, GCS at admission, mechanism of
head injury, ISS, and AIS of the head did not differ sig-
nificantly between the study groups.
Outcomes
Clinical outcomes are summarized in Table 2. The in-
hospital mortality of the intraventricular ICP monitoring
group was significantly lower than that of the non-ICP
monitoring group (33.8 % vs 51.2 %, P < 0.05). The 6-
month GOS score was also higher in the ICP monitoring
group (3.0 ± 1.4 vs 2.5 ± 1.2 P < 0.05). However, patients
with intraventricular ICP monitoring had longer ICU
stays (14.3 ± 6.4 days vs 11.6 ± 5.8 days, P < 0.01) and
longer mechanical ventilation times (6.7 ± 3.5 days vs
5.6 ± 2.4 days, P < 0.01) than patients without ICP moni-
toring. There was no significant difference in the total
length of hospital stay between the two groups (28.5 ±
12.1 days vs 26.1 ± 13.5 days, P = 0.23).
Mannitol administration and CSF drainage
The average dose of mannitol administered in the intra-
ventricular ICP-monitoring group was significantly lower
than that used in the non-ICP monitoring group (514 ±
246 g vs 840 ± 323 g, P < 0.0001). In addition, the dur-
ation of mannitol use was shorter in the ICP monitoring
group (6.7 ± 3.6 days vs 8.4 ± 4.3 days, P < 0.01). The
average volume of CSF drainage was 705 ± 321 ml dur-
ing a period of intraventricular ICP monitoring (7.2 ±
4.3 days) (Table 3).
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Device-related complications
The ICP monitoring-related complications including
true problems such as catheter-induced hemorrhage and
infections and device malfunctions like catheter obstruc-
tion. The incidence rates of infections and hemorrhage
were 3.8 and 8.7 %, respectively. These complications
were managed successfully with conservative treatment.
Six of the 80 (7.5 %) ICP monitoring catheters eventually
ceased draining because of obstruction. Four of the six
catheters became obstructed after the 7th monitored day
and the other two catheters were obstructed on the 4th
and 5th monitored days (Table 4).
Discussion
The aim of this study was to determine the effect of in-
traventricular ICP monitoring on outcome of elder pa-
tients with a severe TBI. The results indicated that elder
severe TBI patients managed with intraventricular ICP
monitoring had lower in-hospital mortality and im-
proved 6-month functional outcome compared with pa-
tients without ICP monitoring. However, the length of
ICU stay and mechanical ventilation duration were lon-
ger in ICP monitored patients. Although ICP monitoring
has long been considered the standard of care for severe
TBI patients and is recommended by several guidelines
[5–7], there are still debates over the effect of ICP moni-
toring on the outcome of severe TBI patients. Two
retrospective studies and a prospective study concluded
that ICP monitoring was associated with decreased in-
hospital or two-week mortality [8–10]. Cremer et al.
conducted a large prospective cohort study in two
medical centers, patients in center A received supportive
care treatment while patients in center B were treated
under the ICP/CPP target protocol (maintaining ICP
<20 mmHg and CPP >70 mmHg). They found no evi-
dence for improved outcome in patients who received
ICP monitoring despite a higher treatment intensity
[12]. Mauritz et al. performed a prospective multi-center
study in Australia, and found the lowest mortality rate
in the subgroup with the highest rate (91.1 %) of ICP
monitoring. However, the differences were not signifi-
cant. Worsening outcome in severe TBI patients with
ICP monitoring was also reported in a retrospective
study [13]. Nevertheless, previous observational studies
have generally suffered from methodological weaknesses,
including: selection bias, difference in treatment proto-
cols, baseline differences between groups in injury sever-
ity, and comorbidities that may cofound the outcomes.
Due to ethical considerations, Chesnut et al. conducted
the only randomized control trial about ICP monitoring
in severe TBI patients, to date. The trial was conducted
in Latin America, where ICP monitoring was not the
standard of care in most hospitals. No difference was
found in the primary outcome, which was a composite
of 21 measures including survival time and 6-month
functional and neuropsychological status, between pa-
tients with or without ICP monitoring [11]. However,
some issues about this trial warrant discussion. First, this
trial was conducted in South America, where the med-
ical system and availability of resources, including pre-
hospital resuscitation and care after hospital discharge,
were less developed than those in higher income
Fig. 1 Flowchart of patient screening and study inclusion. TBI = traumatic brain injury; ICP = intracranial pressure monitoring
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countries [20, 21]. Second, ICP was monitored by intra-
parenchymal monitors and CSF drainage was rarely used
in this trial [20]. Finally, the elderly TBI patients, who
are prominent in developed countries, were not present
in this trial [11].
In our study, patients treated with intraventricular ICP
monitoring had lower in-hospital mortality (33.8 % vs
51.2 %, P < 0.05) and better 6-month functional outcome
(3.0 ± 1.4 vs 2.5 ± 1.2, P < 0.05) than patients without ICP
monitoring. Our findings, in conjunction with multiple
studies reporting on the positive effects of ICP monitor-
ing, add to the beneficial evidence of ICP monitoring in
the management of severe TBI, especially in the elderly
population. Poorer outcomes after brain injury were
often observed among elder adults (aged ≥65 years)
compared with younger patients. Evidence suggested
that elderly patients received less aggressive treatment,
including ICP monitoring, than younger adults [22, 23].
Nevertheless, previous studies have demonstrated that it
would be beneficial to increase the treatment intensity
Table 2 Clinical outcomes with and without ICP monitoring in older patients with severe traumatic brain injury
ICP monitoring group Non-ICP monitoring group P value
Number of patients 80 86
In-hospital mortality, n (%) 27 (33.8) 44 (51.2) 0.035
6-month GOS, Mean ± SD 3.0 ± 1.4 2.5 ± 1.2 0.014
Length of ICU stay (days), Mean ± SD 14.3 ± 6.4 11.6 ± 5.8 0.004
Length of total hospital stay (days), Mean ± SD 28.5 ± 12.1 26.1 ± 13.5 0.23
Length of mechanical ventilation (days), Mean ± SD 6.7 ± 3.5 5.6 ± 2.4 0.019
Table 1 Demographic and baseline characteristics of the study population
ICP monitoring group Non-ICP monitoring group P value
Number of patients 80 86
Age (years) 0.29
Median 74 76
Interquartile range 68–78 69–82
Gender: female, n (%) 46 (57.5) 52 (60.5) 0.71
Chronic conditions, n (%)
Hypertension 42 (52.5) 48 (55.8) 0.79
Coronary heart disease 31 (38.8) 25 (29.1) 0.25
Pulmonary disease 12 (15.0) 11 (12.8) 0.85
Diabetes mellitus 10 (12.5) 12 (14.0) 0.95
GCS on admission, n (%) 0.64
6–8 56 (70.0) 64 (74.4)
3–5 24 (30.0) 22 (25.6)
Mechanism of head injury, n (%)
Falls 43 (53.8) 48 (55.8) 0.91
Traffic accident 24 (30.0) 28 (32.6) 0.85
Others 13 (16.2) 10 (11.6) 0.53
Marshall classification on initial CT, n (%)
Diffuse injury II, 13 (16.3) 27 (31.4) 0.037
Diffuse injury III, 28 (35.0) 20 (23.5) 0.14
Diffuse injury IV, 18 (22.5) 17 (19.8) 0.81
Evacuated mass lesion 9 (11.3) 8 (9.3) 0.87
Nonevacuated mass lesion 12 (14.9) 14 (16.0) 0.98
Abbreviated injury scale for head, Mean ± SD 3.78 ± 0.92 3.80 ± 0.91 0.89
Injury Severity Score (ISS), Mean ± SD 27.5 ± 9.2 28.4 ± 9.5 0.54
The Marshall classification of traumatic brain injury is based on a review of CT scans [1]
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for this group of patients, and elder patients may be
more responsive to treatment for lowering intracranial
hypertension [24, 25]. With ICP monitoring, information
gained allows for more informed decisions regarding the
management of elderly TBI patients.
There are currently two major approaches for continu-
ous ICP monitoring, intraparenchymal and intraventric-
ular, each with its own merits and drawbacks [16, 26].
The benefits of ICP monitoring include maintaining an
adequate CPP, providing an early indication for surgical
management, and guiding the administration of therapy
for lowering ICP [16]. The evidence for the association
between types of ICP monitoring and outcome in TBI
patients are variable [16, 17]. Intraventricular ICP moni-
toring was chosen in this study since it is considered the
most reliable and accurate method of measuring ICP.
Moreover, intraventricular catheters can also provide an
effective means of lowering ICP by drainage of CSF. By
draining CSF with an average volume of 705 ± 321 ml in
this study, the ICP monitoring group received a signifi-
cantly lower dose of mannitol (514 ± 246 g vs 840 ±
323 g, P < 0.0001) and shorter duration of mannitol ad-
ministration (6.7 ± 3.6 days vs 8.4 ± 4.3 days, P < 0.01)
than the control group. It has been established that
mannitol may cause hypovolemia and result in episodes
of hypotension, which has been associated with in-
creased mortality in brain injury patients [27, 28]. Due
to its nephrotoxicity, mannitol can lead to acute kidney
injury (AKI) [29]. A study conducted by Zeng J et al.
suggested that intraventricular ICP monitoring reduced
the incidence of AKI in TBI patients by reducing the use
of mannitol [30]. Often presented with multiple pre-
existing comorbidities, elderly TBI patients were at
higher risk of developing secondary complications, such
as cardiac arrest and acute renal failure, than younger
adults [3]. By reducing the use of mannitol, the benefi-
cial effect of CSF drainage via intraventricular catheters
is amplified in the group of older TBI patients. This may
be another reason for the better outcome observed in
the ICP monitoring group.
With regard to the in-hospital mortality, our results
(overall mortality 42.8 %) were lower than those re-
ported in previous studies. The mortality of severe TBI
patients aged 65 years or older in other studies ranged
from 72 to 83.3 % [31–33]. The lower mortality in our
cohort than other studies could be attributed to the ex-
clusion of the “worst cases” (patients died within 24 h of
brain injury or admitted with a diagnosis of brain death)
in this study.
In this study, the length of ICU stay (14.3 ± 6.4 days vs
11.6 ± 5.8 days, P < 0.01) and duration of mechanical
ventilation (6.7 ± 3.5 days vs 5.6 ± 2.4 days, P < 0.05) were
significantly longer in the ICP monitoring group. How-
ever, conflicting results about this topic have been re-
ported previously [9, 14, 21, 34]. The differing results
about the length of ICU stay can potentially be attrib-
uted to the types of ICP monitoring used. Intraventricu-
lar ICP monitoring was previously associated with
longer ICU lengths of stay than intraparenchymal ICP
monitoring [16]. The ICP monitoring was performed
under general anesthesia; thus, the mechanical ventila-
tion days were significantly longer in the ICP monitoring
group. Nevertheless, the overall hospital stay (28.5 ±
12.1 days vs 26.1 ± 13.5 days, P = 0.23), a parameter more
reflective of injury burden, did not differ between groups
in this study. This can be explained by the similar injury
severities between groups.
The complications associated with intraventricular ICP
monitoring were also analyzed in this study. Six of the
80 (7.5 %) catheters were eventually obstructed and
ceased draining, and this is lower than the rates reported
previously [16]. In our study, most of the catheters (4 of
6) became obstructed after the 7th monitored day with-
out significantly affecting the drainage of CSF. Device-
related infections were seldom observed in this study,
with an occurrence rate of 3.8 %. This was likely due to
the routine prophylactic antibiotic treatment in all pa-
tients who underwent ICP monitoring in our depart-
ment. Hemorrhage associated with catheter insertion
was identified in 8.7 % of patients, but all the cases were
managed successfully with conservative treatment.
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There are several potential limitations of this study.
First, this was an observational study conducted in a sin-
gle institution, and there are inherent limitations of this
type of study. Second, the study was not randomized,
which may reduce its statistical power. Third, the
decision-making process for intraventricular ICP moni-
toring was not entirely standardized. Some patients in
the non-ICP monitoring group met the criteria, but did
not undergo ICP monitoring due to other factors. Thus,
further well-designed, multicenter studies are needed to
confirm the study results.
Conclusion
In our study, older severe TBI patients who underwent in-
traventricular ICP monitoring had lower in-hospital mor-
tality and improved 6-month outcomes compared with
patients without ICP monitoring. These favorable findings
may be attributed to intraventricular ICP monitoring.
However, given the limitations of this study, further well-
designed randomized control trials are needed to confirm
the beneficial effects of intraventricular ICP monitoring
on the outcomes of older severe TBI patients.
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